Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18–25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials

Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 19; no. 1; pp. 1537 - 11
Main Authors Mbunda, Theodora, Tarimo, Edith A. M., Bakari, Muhammad, Sandström, Eric, Kulane, Asli
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 20.11.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy HIV vaccine trials to determine the efficacy of HIV vaccines that had proven to be safe and immune potent. It was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables. The study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent. Respondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.
AbstractList Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy HIV vaccine trials to determine the efficacy of HIV vaccines that had proven to be safe and immune potent.BACKGROUNDDespite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy HIV vaccine trials to determine the efficacy of HIV vaccines that had proven to be safe and immune potent.It was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables.METHODSIt was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables.The study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent.RESULTSThe study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent.Respondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.CONCLUSIONRespondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.
Background Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy HIV vaccine trials to determine the efficacy of HIV vaccines that had proven to be safe and immune potent. Methods It was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables. Results The study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent. Conclusion Respondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.
Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. It was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables. The study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent. Respondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.
Abstract Background Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy HIV vaccine trials to determine the efficacy of HIV vaccines that had proven to be safe and immune potent. Methods It was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables. Results The study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent. Conclusion Respondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.
Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and populations at high. risk for HIV transmission such as sex workers. There is a need to prepare a suitable population that will participate in efficacy HIV vaccine trials to determine the efficacy of HIV vaccines that had proven to be safe and immune potent. It was a cross-sectional study that recruited 600 female sex workers using respondent-driven sampling in Dar es Salaam. The study examined recruitment approaches, risk behaviors and willingness of young female sex workers to participate in an HIV vaccine trial. Descriptive statistics described risk behaviors and willingness of the participants to participate in efficacy HIV vaccine trials. The logistic regression model computed the likelihood of willingness to participate in the trials with selected variables. The study demonstrated 53% were less than 20 years old, 96% were single, and 22% lived in brothels. Eighty percent of the participants started selling sex at the age between 15 and 19 years old, 61% used illicit drugs for the first time when they were less than 20 years old, 24% had anal sex ever. Eighty-nine percent had more than 20-lifetime sexual partners, and 56% had unprotected sexual intercourse with sex clients. Ninety-one percent expressed a willingness to participate in the HIV vaccine trial. Sixty-one percent did not need permission from anyone for participating in a trial. Ninety-one percent expressed willingness to participate in the efficacy of HIV vaccine trial. In the logistic regression model, willingness was significantly associated with the need to ask permission for participation in HIV vaccine trial from sex agent. Respondent-driven sampling provided a rapid means of reaching young female sex workers who reported high-risk behaviors. The majority expressed a high level of willingness to participate in the HIV vaccine trial which was marginally correlated to the need to seek consent for participation in the trial from the sex brokers. Future HIV vaccine trials involving this population should consider involving the brokers in the trials because they form an essential part of the community for the participants.
ArticleNumber 1537
Audience Academic
Author Kulane, Asli
Tarimo, Edith A. M.
Sandström, Eric
Mbunda, Theodora
Bakari, Muhammad
Author_xml – sequence: 1
  givenname: Theodora
  surname: Mbunda
  fullname: Mbunda, Theodora
– sequence: 2
  givenname: Edith A. M.
  surname: Tarimo
  fullname: Tarimo, Edith A. M.
– sequence: 3
  givenname: Muhammad
  surname: Bakari
  fullname: Bakari, Muhammad
– sequence: 4
  givenname: Eric
  surname: Sandström
  fullname: Sandström, Eric
– sequence: 5
  givenname: Asli
  surname: Kulane
  fullname: Kulane, Asli
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31796002$$D View this record in MEDLINE/PubMed
BookMark eNp9ks9OFTEUxicGI3_0AdyYJm4wYXDa-dOZjQlBFBISE0W3zZn29FKYaa_tzOXiiq1rn8kX4UnscJEAMaaLNqe_72t7-m0ma9ZZTJKXNNultK7eBsrqukkz2qS8ZixdPkk2aMFpyoqyXru3Xk82QzjLMsrrkj1L1nPKmyrL2Eby-zNKP5qhRzuQMRg7Ix7D3Fk1FZQ3C7QkQD_v4tYO8SackxZPYWGcDwRCwBButGAVuTDdhNlYI06TSzdGO409dEgCLsmF8-cYZdu0vr76xcrrq5-XCD68IcaS9-DJQSBfoAPod8gJ2B9gDZDBkTn4wUgzhwEn8vDoG1mAlMYiGbyBLjxPnuo44YvbeSv5-uHgZP8wPf708Wh_7ziVJc2XaQGtKlTe5BqhbVUJmDGoioLrstW1QlbmTVNWOdO8yEvkPOcNatZCRRvJWJ1vJUcrX-XgTMy96cFfCgdG3BScn4mbq3YoqK6qtlANrbkqpMKGlQx0LktoizrnEL3erbzmY9ujkrGJHroHpg93rDkVM7cQVfzzitNosH1r4N33EcMgehMkdh1YdGMQLGe0qmIGmoi-foSeudHb2KqJqpuiLIt71Cx-mDBWu3iunEzFXpXxpuZ5wSK1-w8qDoW9kTGg2sT6A8Gr-w-9e-HfEEaArgDpXQge9R1CMzEFXayCLmLQxRR0sYwa_kgjzQCDcVOvTPcf5R8rYAay
CitedBy_id crossref_primary_10_3389_fpubh_2024_1359363
crossref_primary_10_1186_s12889_020_09932_7
Cites_doi 10.1007/s11524-006-9052-7
10.1111/j.0081-1750.2004.00152.x
10.3109/14659891003721141
10.1371/journal. pone.0168660
10.1186/1471-2458-13-1149
10.3402/gha.v7.22853
10.1371/journal.pone.0119629
10.2307/3096941
10.1214/14-EJS923
10.1097/QAI.0000000000001203
10.1371/journal.pone.0001954
10.1056/NEJMoa1310566
10.4161/hv.22903
10.1007/s10461-008-9486-x
10.1198/jasa.2011.ap09475
10.1056/NEJMoa0908492
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-019-7822-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1471-2458
EndPage 11
ExternalDocumentID oai_doaj_org_article_1f66b4d9187d4cde9252af3c5ab4837a
PMC6889671
A607987342
31796002
10_1186_s12889_019_7822_x
Genre Journal Article
GeographicLocations Tanzania
Sub-Saharan Africa
Zanzibar
Africa
GeographicLocations_xml – name: Tanzania
– name: Sub-Saharan Africa
– name: Africa
– name: Zanzibar
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7T2
7XB
8FK
AZQEC
C1K
DWQXO
EJD
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c513x-4abd4d393feabbd5ae02a6447f5bf8de253995632f7435e77379ef2ba619c2283
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 01:23:10 EDT 2025
Thu Aug 21 18:24:09 EDT 2025
Fri Jul 11 15:49:16 EDT 2025
Fri Jul 25 19:12:34 EDT 2025
Tue Jun 17 21:50:51 EDT 2025
Tue Jun 10 20:36:44 EDT 2025
Wed Feb 19 02:31:32 EST 2025
Thu Apr 24 22:57:22 EDT 2025
Tue Jul 01 00:55:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c513x-4abd4d393feabbd5ae02a6447f5bf8de253995632f7435e77379ef2ba619c2283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12889-019-7822-x
PMID 31796002
PQID 2328945549
PQPubID 44782
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_1f66b4d9187d4cde9252af3c5ab4837a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6889671
proquest_miscellaneous_2321661479
proquest_journals_2328945549
gale_infotracmisc_A607987342
gale_infotracacademiconefile_A607987342
pubmed_primary_31796002
crossref_primary_10_1186_s12889_019_7822_x
crossref_citationtrail_10_1186_s12889_019_7822_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-20
PublicationDateYYYYMMDD 2019-11-20
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-20
  day: 20
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References T Mbunda (7822_CR27) 2016; 11
DREAMS, Population Council (7822_CR8) 2017
J Salganik (7822_CR17) 2004; 34
F van Loggerenberg (7822_CR23) 2008; 3
D Heckathorn (7822_CR15) 1977; 44
7822_CR20
RN Supachai (7822_CR12) 2009; 361
F Etcheverry (7822_CR24) 2010; 14
S Hammer (7822_CR11) 2013; 369
S Hedden (7822_CR25) 2011; 16
A Abdul-Quader (7822_CR22) 2006; 83
M Handcock (7822_CR19) 2014; 8
M Deschamps (7822_CR26) 2013; 34
7822_CR16
K Gile (7822_CR18) 2011; 106
PJ Munseri (7822_CR10) 2015; 10
F Etcheverry (7822_CR7) 2013; 9
National AIDS Control Program, NACP. HIV AND STI Biological and Behavioral Survey, 2013 (7822_CR5) 2013
7822_CR6
7822_CR13
7822_CR1
7822_CR2
7822_CR3
7822_CR4
T Mbunda (7822_CR14) 2014; 7
M Bakari (7822_CR21) 2013; 13
D Kerrigan (7822_CR9) 2017; 74
References_xml – volume: 83
  start-page: 459
  issue: 3
  year: 2006
  ident: 7822_CR22
  publication-title: J Urban Health
  doi: 10.1007/s11524-006-9052-7
– volume: 34
  start-page: 193
  year: 2004
  ident: 7822_CR17
  publication-title: Sociol Methodol
  doi: 10.1111/j.0081-1750.2004.00152.x
– volume: 16
  start-page: 57
  issue: 1
  year: 2011
  ident: 7822_CR25
  publication-title: J Subst Use
  doi: 10.3109/14659891003721141
– volume: 11
  start-page: e0168660
  issue: 12
  year: 2016
  ident: 7822_CR27
  publication-title: PLoS One
  doi: 10.1371/journal. pone.0168660
– volume: 13
  start-page: 1149
  year: 2013
  ident: 7822_CR21
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-13-1149
– volume: 7
  start-page: 22853
  year: 2014
  ident: 7822_CR14
  publication-title: Glob Health Action
  doi: 10.3402/gha.v7.22853
– ident: 7822_CR20
– volume: 10
  start-page: e0119629
  issue: 4
  year: 2015
  ident: 7822_CR10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0119629
– ident: 7822_CR3
– ident: 7822_CR13
– volume: 44
  start-page: 174
  issue: 2
  year: 1977
  ident: 7822_CR15
  publication-title: Soc Probl
  doi: 10.2307/3096941
– volume-title: Final report on Considerations for PreP introduction to adolescent girls and young women in Tanzania: Findings from implementation science research
  year: 2017
  ident: 7822_CR8
– volume: 8
  start-page: 1491
  issue: 1
  year: 2014
  ident: 7822_CR19
  publication-title: Electron J Stat
  doi: 10.1214/14-EJS923
– volume-title: A study of female sex Workers in Seven Regions: Dar es Saaam, Iringa, Mbeya, Mwanza, Shinyanga, Tabora and Mara
  year: 2013
  ident: 7822_CR5
– volume: 74
  start-page: S60
  issue: 1
  year: 2017
  ident: 7822_CR9
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000001203
– volume: 3
  start-page: e1954
  issue: 4
  year: 2008
  ident: 7822_CR23
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0001954
– ident: 7822_CR1
– volume: 369
  start-page: 2083
  issue: 22
  year: 2013
  ident: 7822_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1310566
– volume: 9
  start-page: 420
  issue: 2
  year: 2013
  ident: 7822_CR7
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.22903
– volume: 34
  start-page: 92
  issue: 2
  year: 2013
  ident: 7822_CR26
  publication-title: Rev Panam Salud Publica
– volume: 14
  start-page: 607
  year: 2010
  ident: 7822_CR24
  publication-title: AIDS Behav
  doi: 10.1007/s10461-008-9486-x
– ident: 7822_CR4
– ident: 7822_CR6
– ident: 7822_CR16
– volume: 106
  start-page: 135
  issue: 493
  year: 2011
  ident: 7822_CR18
  publication-title: American J Stat Assoc
  doi: 10.1198/jasa.2011.ap09475
– volume: 361
  start-page: 2209
  year: 2009
  ident: 7822_CR12
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908492
– ident: 7822_CR2
SSID ssj0017852
Score 2.2883155
Snippet Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and...
Background Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young women and...
Abstract Background Despite the present HIV preventive and treatment programs, the prevalence of HIV is still high in eastern and southern Africa, among young...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1537
SubjectTerms Adolescent
Adult
AIDS vaccines
AIDS Vaccines - therapeutic use
Anal sex
Behavior
Birth control
Brokers
Clinical trials
Clinical Trials as Topic
Consent
Counseling
Cross-Sectional Studies
Discount coupons
Disease prevention
Disease transmission
Female
Females
HIV
HIV Infections - prevention & control
HIV Infections - psychology
Human immunodeficiency virus
Humans
Illegal drugs
Immunosuppressive agents
Infections
Logistic Models
Participation
Patient Participation - statistics & numerical data
Peers
Population
Public health
Recruiting
Recruitment
Regression models
Reproductive health
Research Subjects - statistics & numerical data
Researchers
Risk taking
Sampling
Seeds
Sex
Sex industry
Sex oriented businesses
Sex Workers - statistics & numerical data
Sexual behavior
Sexual intercourse
Sexual partners
Sexually transmitted disease prevention
Sexually transmitted diseases
Social exclusion
STD
Stigma
Studies
Surveys and Questionnaires
Tanzania - epidemiology
Transgender persons
Vaccines
Women
Workers
Working women
Young Adult
Young adults
Young women
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT0gI8c1CQYOExIcadePEcXws0GrhwIUW9WZNErtdqc1Wm13Y3nrlzG_ij_SXMONko42Q4MI1nkixPZ55zjw_C_EyQz-WJq6i2Ks0SmmLEaFWtPCMNlLHqL0LbIvP2eQo_XSsjjeu-mJOWCsP3A7cbuyzrEgrE-e6SsvKGakk-qRUWLAYeoBGlPPWm6mufqBzJbsaZpxnuw1FYaYGxSbijBitBlkoiPX_GZI3ctKQL7mRgA7uiNsdcoS99ovvihuuvidutb_doD1NdF_8Yhi4nAbqODCn_QTmgQXL53GhmnNsgwaZRl6f7AATy2F9Ur8B7GU6AesKvk-DYDcHQ5h5uOTAAN6dUwegcStgThehR3gd59dXP6W6vvpxSQuneQPTGj7gHPYb-IJniOc7cEgYFOspwmIGF7jmcju2nHz8Ct-w5Ao_hEtEmgfi6GD_8P0k6m5qiEoVJ6soxaJKq8Qk3mFRVArdWCIhLe1V4fPKSRVO0CbSE2BRTutEG-dlgbR9K1mA56HYqme1eyxA-qzMCEMwNmThxIIl7RTSdBuuvJmRGK9nzpadjDnfpnFmw3Ymz2w72ZYm2_Jk29VIvO1fuWg1PP5m_I7doTdk-e3wgJzSdk5p_-WUI_GKnclykKCPK7E760BdZLktu5eNtcl1ksqR2B5Y0uIuh81rd7RdcGksgeDcpIQDaTBe9M38JhPmajdbBpuYoZcmm0et9_ZdIshouBw7Enrg14M-D1vq6WmQHs9osDIdP_kfg_RU3JS8Iik8yPG22FrMl-4ZIbxF8Tws5t_sS1Fp
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgXJAQ4ptAQYOExIcade3EcXxCBbosHLjQot4iJ7GXldpk2ezC9tYrZ34Tf6S_hBknGxoh9bqeSPbaM_PseX5m7Hli3EhoXobcyTiMcYsRGiXR8bTSQnGjnPVsi8_J5DD-dCSPugO3pqNVbmKiD9RlXdAZ-S5m_lTHmPz0m_n3kF6Noupq94TGVXaNY6YhSlc6_tBXEVQqRVfJ5Gmy22AsJoIQ1yHlxXA9yEVesv__wHwhMw1ZkxfS0PgWu9nhR9hrJ_w2u2KrO-xGe_gG7Z2iu-wPgcHVzBPIgZjtU1h4LizdyoVyQREOGkNk8mq6A0Qvh819_QZML9YJpirh58zLdlNIhNrBKYUHcPYEBwCNXQMxuxBDwkuenp_9FvL87Ncpuk_zCmYVvDcL2G_gizk25mQHDhCJmmpmYFnD3GwY3ZYsJx-_wg9TUJ0f_FMizT12ON4_eDcJu_cawkLyaB3GJi_jMtKRsybPS2nsSBjEW8rJ3KWlFdLfo42EQ9girVKR0taJ3OAmriAZnvtsq6or-5CBcEmRIJIghEjyiTkJ20kjTa6p_qYDNtrMXFZ0Yub0psZx5jc1aZK1k53hZGc02dk6YK_7T-atksdlxm9pOfSGJMLtf6gX06zz6Yy7JMnjUvNUlXFRWuynMC4qsJek028C9oIWU0ahAjtXmO7GAw6RRLeyvWSkdKqiWARse2CJLl4MmzfLMetCTJP9c4iAPeub6UuizVW2XnkbTgBMoc2DdvX2Q0LgqKkoGzA1WNeDMQ9bqtk3L0Ce4J-VKP7o8m49ZtcF-Rq6vxhts63lYmWfIIJb5k-9m_4F5dJIdw
  priority: 102
  providerName: ProQuest
Title Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18–25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials
URI https://www.ncbi.nlm.nih.gov/pubmed/31796002
https://www.proquest.com/docview/2328945549
https://www.proquest.com/docview/2321661479
https://pubmed.ncbi.nlm.nih.gov/PMC6889671
https://doaj.org/article/1f66b4d9187d4cde9252af3c5ab4837a
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfG9oKEEN8URnVISEhogcb5cPyA0DpaChITGiuqeLGcxC6VunQkLXR_F_8gd25SFjHtxQ_xJfLH3fnn-Pw7xl7E2va49HPPt1HohbjF8LSI0PCkkFz4Wljjoi2O49E4_DSJJjusSW9VD2B15daO8kmNy_nr9c-Ld2jwb53BJ_GbCn0sBf740qP1zkNIuYcLk6CEBp_Df4cKInEJeHz0xx4Po6Q-5LzyE61lyrH5_--zLy1a7YDKSyvU8A67XUNLONzowl22Y4p77NbmvxxsrhvdZ38IJ65mLrYcKOh9CqULk6ULu5CX5Pyg0hRnXkwPgCLPobnKX4He8niCLnL4PXOM3uQtYWHhgjwHWHOGHYDKrIGCvhBewqyA97qEQQVf9VzrswM4RUiqi5mG5QLOdRPabUhy9PEb_NIZHfiDyylSPWDj4eD0aOTViRu8LPKDtRfqNA_zQAbW6DTNI216XCPwEjZKbZIbHrkLtQG3iF8iI0QgpLE81biby4iP5yHbLRaFecyA2ziLEVIQVCQexZQY7iId6VTSQZzssF4zTyqrWc0pucZcud1NEqvN1CqcWkVTq9Yd9mr7yvmG0uM64T5N_laQ2Ljdg0U5VbVxK9_GcRrm0k9EHma5wXZybYMMW0mE_brDXpLqKNJibFym66sP2EVi31KHcU_IRAQh77D9liTaetaubpRPNaaiEBMnMkRYiIPxfFtNb1L8XGEWKyfjExITKPNoo6vbLiGClHQ622GipcWtPrdritkPx0Qe42DFwn9yfaufspucLAv9AO_ts91luTLPEMot0y67ISYCy-TIp3L4ocv2-oPjLydd93Ok6wwYy5P-979O20wv
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKOYCEEP8sFBgkED9q1I3z4_iAUKEtu7T0whb1ZpzEXlZqs8umpdtbr5x5D96CF-mTMOMkSyOk3npdT1Z2ZvzNOP5mhrFnsbZdLv3c820UeiEeMTwtItx4UkgufC2scWyL7bi3E37cjXYX2O8mF4ZolQ0mOqDOxxl9I19Bz5_IEJ2ffDv57lHXKLpdbVpoVGaxaY6P8MhWvumvoX6fc76xPnjf8-quAl4W-cHMC3Wah3kgA2t0muaRNl2uMSoQNkptkhseuWzPgFt0rpERIhDSWJ5qPGpkVCwG__cSuxwG6MkpM33jw_zWQiQRr29O_SReKRH7iZDkS4_8sDdr-T7XIuB_R3DGE7ZZmmfc3sYNdr2OV2G1MrCbbMEUt9i16mMfVDlMt9kfCj4PR46wDsSkH8LUcW8pCxjyKSEqlJrI68VwGYjODk19gBL0vDgo6CKHo5ErE04QDGMLxwRHYM0-LgBKMwNikmHMCi_95PTkF49OT34eo17KVzAqYE1PYb2Ez3pP6_1lGGDkq4uRhoMxTHTDIDck2et_gR86I14BuNYl5R22cyGavMsWi3Fh7jPgNs5ijFwoIqVyjSkV0ot0pFNJ932yw7qN5lRWF0-nHh57yh2iklhVylaobEXKVrMOez1_ZFJVDjlP-B2Zw1yQin67H8bToaoxRPk2jtMwl34i8jDLDc6TaxtkOEvqC6A77AUZkyJowsllus6wwCVSkS-1GneFTEQQ8g5bakkipGTt4cYcVQ1ppfq3ATvs6XyYniSaXmHGh07Gp4BPoMy9ynrnS8JAVdIlcIeJll231tweKUbfXMHzGF9WLPwH50_rCbvSG3zaUlv97c2H7CqnfYfQw7tLbPFgemgeYfR4kD52WxbY14vGiL_Iq4Wp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recruitment+using+respondent+driven+sampling%2C+risk+behaviors+assessment+and+willingness+of+young+female+sex+workers+in+Dar+Es+Salaam%2C+Tanzania+to+participate+in+HIV+vaccine+trials&rft.jtitle=BMC+public+health&rft.au=Mbunda%2C+Theodora&rft.au=Tarimo%2C+Edith+A.+M&rft.au=Bakari%2C+Muhammad&rft.au=Sandstr%C3%B6m%2C+Eric&rft.date=2019-11-20&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12889-019-7822-x&rft.externalDocID=A607987342
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon